Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01517334 · ClinicalTrials.gov registry record · Phase 3
Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)
A Phase 3 study of Peri Implantitis, sponsored by OraPharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 208
- Enrollment target
- 10
- Study locations
NCT01517334 is a Phase 3 study of Peri Implantitis that has completed, run by OraPharma. The registered enrollment target is 208 participants, above the 68-participant average among 4 other Peri Implantitis trials with a reported enrollment target (206% higher). The trial reports 10 study locations across 10 states.
The verdict
NCT01517334, a Phase 3 study of Peri Implantitis, has completed, sponsored by OraPharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 208 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of the study is to evaluate the safety, effectiveness and anti-microbial effects of Arestin (minocycline HCl) 1 mg Microspheres in the treatment of subjects with peri-implantitis, when used in combination with mechanical debridement. The hypothesis of the study is that Arestin in combination with mechanical debridement is more effective in the treatment of peri-implantitis when compared to mechanical debridement alone. The primary efficacy measure will be the reduction of probing depth at Day 180 as measured at qualifying implant sites.
Conditions Studied
Interventions
- DRUG Minocycline HCl Microspheres
Study Locations (10)
Maryland
- University of Maryland, School of Dentistry - Baltimore
Massachusetts
- Tufts University School of Dental Medicine - Boston
Michigan
- University of Michigan - Michigan Center for Oral Health Research - Ann Arbor
Missouri
- University of Missouri - Kansas City School of Dentistry Clinical Research Center - Kansas City
North Carolina
- University of North Carolina at Chapel Hill School of Dentistry - Chapel Hill
Pennsylvania
- University of Pennsylvania School of Dental Medicine - Philadelphia
South Carolina
- Medical University of South Carolina College of Dental Medicine - Charleston
Tennessee
- UTHSC - College of Dentistry - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01517334
The ClinicalTrials.gov registry entry for NCT01517334 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 68-participant average among 4 other Peri Implantitis trials with a reported enrollment target (206% higher). The listed sponsor is OraPharma, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peri Implantitis appearing as the primary indexed condition, and to 1 intervention - of which Minocycline HCl Microspheres is the first listed.
NCT01517334 reports 10 study locations spanning 10 distinct geographic areas - top geographies include Maryland, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT01517334 about?
NCT01517334 is a clinical study titled "Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)". The objective of the study is to evaluate the safety, effectiveness and anti-microbial effects of Arestin (minocycline HCl) 1 mg Microspheres in the treatment of subjects with peri-implantitis, when used in combination with mechanical debridement. The hypothesis of the study is that Arestin in comb...
What is the current status of trial NCT01517334?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 208 participants. The study started on 2012-05. Estimated completion is 2014-11.
What conditions does trial NCT01517334 study?
This clinical trial studies the following conditions: Peri Implantitis.
What interventions are being tested in trial NCT01517334?
The interventions under investigation include: Minocycline HCl Microspheres (DRUG).
Who is sponsoring clinical trial NCT01517334?
This trial is sponsored by OraPharma, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01517334 being conducted?
This trial has 10 study locations across Maryland, Massachusetts, Michigan, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peri Implantitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immediate Versus Delayed Surgical Reconstruction of Peri-implantitis Intra-bony Defects.
RECRUITING · NA
-
Antiseptic Effects on the Dental Implant Internal Surface Microbiome
RECRUITING · Early Phase 1
-
Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology
COMPLETED · NA
-
The Effect of Obesity on Oral Peri-implant Health - A Cross-Sectional Study
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.